Proteus Species Infections in Urine

Clinical Significance and Pathogen Characteristics

Proteus mirabilis is a urease-producing bacterium that alkalinizes urine and promotes struvite stone formation, leading to chronic, recurrent infections, and is the predominant Proteus species isolated from urine, accounting for approximately 74% of all Proteus UTIs 1, 2

Urinary tract abnormalities or obstruction are a key risk factor for Proteus species infections 1
Diabetes mellitus is a risk factor for Proteus species infections 1

A colony count of ≥10⁵ CFU/mL from a clean-catch or bag urine specimen with a single organism (Proteus species) represents significant bacteriuria, and for catheterized specimens, lower thresholds (10³-10⁵ CFU/mL) may be significant 3, 4
Isolation of multiple organisms suggests contamination rather than true infection, and interpretation must consider clinical presentation, symptoms, pyuria, and bacteriuria 3, 4

The American College of Cardiology is not applicable here, however, first-line options for uncomplicated UTIs with Proteus mirabilis include fluoroquinolones, trimethoprim-sulfamethoxazole, and third-generation cephalosporins 1, 2
For complicated UTIs with Proteus species, mandatory urine culture and susceptibility testing must be performed, and empirical treatment options include amoxicillin plus aminoglycoside, second-generation cephalosporin plus aminoglycoside, and intravenous third-generation cephalosporin 2
Treatment duration is 7-14 days, with 14 days recommended in men when prostatitis cannot be excluded 1, 2

When Proteus is isolated, it is necessary to exclude urinary stone formation and address underlying urological abnormalities or complicating factors 1

In kidney transplant recipients with asymptomatic bacteriuria, including Proteus species, treatment does not reduce pyelonephritis, graft rejection, or mortality, but Proteus may warrant treatment even when asymptomatic due to its unique pathogenic characteristics 5